Table 3.
Clinical follow up
| Outcomes | 30 days | 6 months | 1 year |
|---|---|---|---|
| All death | 3 (0.5) | 9 (1.4) | 14 (2.2) |
| Cardiac de | 3 (0.5) | 7 (1.1) | 9 (1.4) |
| MI (non-fatal) | 2 (0.3) | 4 (0.6) | 5 (0.8) |
| Target vessel reinfarction | 2 (0.3) | 3 (0.5) | 3 (0.5) |
| Any revascularization | 5 (0.8) | 9 (1.4) | 11 (1.7) |
| TLR (clinical driven) | 3 (0.5) | 5 (0.8) | 8 (1.2) |
| Device oriented endpoint β | 7 (1.1) | 13 (2) | 18 (2.7) |
| Patient oriented endpoint § | 9 (1.4) | 19 (3) | 26 (4.2) |
| Stent thrombosis * | 3 (0.5) | 4 (0.6) | 4 (0.6) |
| Definite | 2 (0.3%) | 2 (0.3%) | 2 (0.3%) |
| Probable | 1 (0.15%) | 2 (0.3%) | 2 (0.3%) |
| Major and minor bleeding | 3 (0.5) | 7 (1.1) | 9 (1.5) |